Higher retention rates among students who complete prevention training
Alcohol and sexual assault prevention training positively impacts student retention
In an effort to ensure the health and safety of students at the University of Cincinnati, incoming students are expected to complete two online trainings: AlcoholEdu and Sexual Assault Prevention. For the past six years, new students (undergraduate, graduate, and transfer) have been encouraged to complete online prevention trainings.
Recently, the Student Wellness Center and the Division of Student Affairs worked with Institutional Research to explore retention rates of students who complete the trainings compared to those who do not complete the trainings. The results show that for AlcoholEdu, full-time undergraduate students who completed the training in Fall 2017 were more likely to be retained into Fall 2018. Across all three UC campuses, the retention rate differences were statistically significant at 0.01.
Completion rates for Fall 2019 also increased substantially compared to previous semesters. As of September 24, completion rates for all campuses and student status (graduate and undergraduate) increased by at least 10%. “This is really exciting news as it means that more of our students are getting the information they need to stay safe and reduce their risk for negative health outcomes,” reports Brandy Reeves, director of the Student Wellness Center. She added, “we are hoping to continue to see completion increases each semester.”
Students who are starting in Spring semester 2020 will be notified of the training this month. If you work with incoming students, encourage them to check their email and to complete the online trainings prior to arrival at UC.
Related Stories
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.